METTL14 reportedly curbs the metastasis of colorectal cancer cells by inhibiting the m6A modification of SRY-box transcription factor 4 (SOX4) mRNA, a mechanism reliant on the YTHDF2-mediated mRNA degradation pathway [22]. Here, METTL14 is linked to colorectal cancer.